Goldman Sachs adds IMCD to conviction list: IMCD stock sits 3.41 percent below its yearly high

Published on 10/20/2026 at 11:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Goldman Sachs cited improving earnings prospects on October 1, 2026. IMCD stock costs EUR 101.95 on October 20, 2026, 3.41 percent below its high.

Analyst view and reporting dates

On October 1, 2026, Goldman Sachs added IMCD to its October conviction list.
In the first half of 2026, operating EBITA reached EUR 285 million, up 8.00 percent on a constant currency basis.
IMCD stock trades at EUR 101.95 at 11:06 a.m. CEST at Lang & Schwarz on October 20, 2026.
IMCD will publish its first nine months 2026 results on November 5, 2026, followed by full-year results on February 19, 2027.

Aquarellbild der Rotterdamer Hafenskyline mit Kränen und Schiffen bei Dämmerung — Aquarellmalerei des Rotterdamer Hafens symbolisiert Standort von IMCD N.V., ISIN NL0010801007, künstlerisch und stimmungsvoll, Illustration mit AI erstellt.

IMCD (ISIN NL0010801007) was trading at EUR 101.95 at Lang & Schwarz on October 20, 2026 at 11:06 a.m. CEST, 3.41 percent below its 52-week high of EUR 105.55. Investing.com reported on October 1, 2026, that Goldman Sachs had added IMCD to its October conviction list.

Goldman sees earnings potential

Goldman Sachs cited improving earnings prospects, valuation and the possibility of stronger demand. The bank also cut its third-quarter 2026 sales estimate by 0.50 percentage points and its adjusted EBITA forecast by 1.40 percentage points, while keeping the list change separate from its underlying investment rating, according to Investing.com.

What does the margin picture show?

IMCD's first-half 2026 results combined higher operating profit with a lower gross profit margin in the second quarter. Operating EBITA rose 8.00 percent on a constant currency basis to EUR 285 million, while gross profit reached EUR 658 million, according to the Yahoo Finance transcript dated July 29, 2026. Gross profit margin was 24.9 percent in the second quarter, 0.7 percentage points below the prior-year quarter. Free cash flow increased to EUR 222 million in the first half.

Three milestones shape the timeline

On July 29, 2026, IMCD reported first-half operating EBITA of EUR 285 million and free cash flow of EUR 222 million, as documented by Yahoo Finance. On October 1, 2026, Goldman Sachs placed IMCD on its October conviction list with a 0.50 percentage-point reduction to its third-quarter sales estimate, according to Investing.com. On October 15, 2026, IMCD's results webcast invitation set the first nine months release for November 5, 2026, as reported by FinanzNachrichten.

Two dates matter next

IMCD's next scheduled reporting date is November 5, 2026, for the first nine months of 2026. The company then plans to publish full-year 2026 results on February 19, 2027, according to its investor-relations calendar at IMCD.

Stock remains below its yearly peak

IMCD is listed on Euronext Amsterdam under the symbol IMCD and operates in specialty chemicals and ingredients distribution. Its market capitalization was EUR 6.0 billion as of October 20, 2026, while the 52-week range stood at EUR 68.14 to EUR 105.55. The Lang & Schwarz quote showed IMCD at EUR 101.95 on October 20, 2026 at 11:06 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of IMCD stock.